Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.67 |
| ▸ | AGXT | P21549 | 2/20 | 0.67 |
| ▸ | MAOB | P27338 | 6/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.56 |
| ▸ | MMP1 | P03956 | 2/20 | 0.54 |
| ▸ | MMP2 | P08253 | 2/20 | 0.54 |
| ▸ | MMP9 | P14780 | 2/20 | 0.54 |
| ▸ | MMP12 | P39900 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3768643 | 0.83 | IDO1 (0.71) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL31264 | 0.83 | IDO1 (0.71) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL6205292 | 0.81 | IDO1 (0.62) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL27886344 | 0.80 | IDO1 (0.67) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL1144902 | 0.80 | IDO1 (0.67) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL1520782 | 0.80 | IDO1 (1.00) | IDO1AGXTMAOBTAAR1 | |
| SCHEMBL28556983 | 0.79 | MMP1 (0.61) | IDO1AGXTMAOBTAAR1MMP1 | |
| SCHEMBL6680175 | 0.79 | IDO1 (0.61) | IDO1AGXTMAOBTAAR1CHRM2 | |
| SCHEMBL31326237 | 0.79 | MMP1 (0.61) | IDO1AGXTMAOBTAAR1MMP1 | |
| SCHEMBL29587500 | 0.79 | TAAR1 (0.60) | IDO1AGXTMAOBTAAR1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3148345-A1 | METHOD FOR REFINING LIPID PHASES, AND USE | Drei Lilien Pvg GmbH&Co. KG (DE) | 2017-04-05 | — | — | EP | disclosed |
| WO-2015181341-A1 | METHOD FOR REFINING LIPID PHASES, AND USE | DREI LILIEN PVG GMBH & CO. KG (DE) | 2015-12-03 | — | — | WO | disclosed |
| EP-2171048-A1 | COMPOSITIONS COMPRISING PERHYDROLASES AND ALKYLENE GLYCOL DIACETATES | Henkel AG & Co. KGaA (DE) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009015951-A1 | COMPOSITIONS COMPRISING PERHYDROLASES AND ALKYLENE GLYCOL DIACETATES | HENKEL AG & CO. KGAA (DE) | 2009-02-05 | — | — | WO | disclosed |
| WO-2007147815-A1 | DENTAL TREATMENT COMPOSITION WITH INCREASED BLEACHING EFFECT | HENKEL AG & CO. KGAA (DE) | 2007-12-27 | — | — | WO | disclosed |
| CN-1241535-C | Cosmetic compositions | UNILEVER NV (NL) | 2006-02-15 | — | — | CN | disclosed |
| EP-1517880-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | Symrise GmbH & Co. KG (DE) | 2005-03-30 | — | — | EP | disclosed |
| CN-1543335-A | Cosmetic compositions | — | 2004-11-03 | — | — | CN | disclosed |
| WO-2004000787-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE GMBH & CO. KG (DE) | 2003-12-31 | — | — | WO | disclosed |